Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02685163
Other study ID # Rif: 3727, Prot: 2325/15
Secondary ID
Status Completed
Phase N/A
First received February 8, 2016
Last updated February 18, 2016
Start date July 2015
Est. completion date December 2015

Study information

Verified date February 2016
Source University of Roma La Sapienza
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

Formation of reactive oxygen species (ROS) contributes to pathogenesis and progression of several diseases. Polyphenols, have been shown to be beneficial against ROS.

This study evaluate the effects of a natural antioxidant ice-cream,rich in polyphenols, on oxidative stress, vascular function and physical performance. In this controlled, single-blind cross-over study, 14 healthy subjects were randomized to assume 100 mg of antioxidant ice-cream consisting of dark cocoa powder, extract of hazelnut and green tea, or milk chocolate ice-cream (control ice-cream). Subjects were studied at baseline and two hours after the ingestion of the ice-creams. Serum polyphenols, antioxidant status (ferric reducing ability of plasma, FRAP), NO bioavailability (NOx), markers of oxidative stress (D-Roms and H2O2), endothelium function (FMD and RHI) and exercise tolerance (Stress Test) with measurement of the double product were assessed.


Description:

14 healthy, non-smoking, volunteers (7 males ), aged between 20 and 40 years were enrolled. The study was randomized, placebo-controlled. After enrollment, 3 days before entering the study, all subjects performed an exercise stress test. They were then randomly allocated to the treatment sequence with 100 mg of natural anti-oxidant ice cream or milk chocolate ice-cream (control icecream) in a cross-over single-blind design. There was 1 week wash-out between 2 phases of the study.

Markers of oxidative stress (D-ROMs and H2O2); serum antioxidant status (FRAP), NO bioavailability (NOx), the endothelium flow-mediated vasodilation (FMD and the RHI by Endopat 2000) were evaluated in fasting condition at baseline (time 0) and 2 hours after the ingestion of the anti-oxidant or control ice-creams. The exercise stress test was performed before randomization and 2 hours after each ice-cream meal test. In both experiments, the ice-cream was consumed within 10 min.

Each subject was asked to refrain from any kind of medication, diet integrators, intensive physical activity and to avoid consumption of polyphenols rich foods, such cocoa-containing products, red wine, tea within the previously 2 weeks. All participants gave written informed consent, and the study was approved by the Medical Ethics Committee of La Sapienza University of Rome (Rif: 3727, Prot: 2325/15).


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date December 2015
Est. primary completion date October 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- healthy, non-smoking, volunteers

Exclusion Criteria:

- Assumption of any kind of medication, diet integrators, intensive physical activity and to avoid consumption of polyphenols rich foods, tea within the previously 2 weeks.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Antioxidant ice-cream
Narutal Antioxidant ice-cream
Control Ice-cream
Natural Control Ice-cream

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Roma La Sapienza

References & Publications (1)

Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008 Jul;88(1):38-50. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Endothelial function Endothelial function will be performed By Endopat2000 and FMD Acute 2 hours No
See also
  Status Clinical Trial Phase
Withdrawn NCT06460194 - Treatment of Frostbite Sequelae With Botulinum Toxin A Phase 2
Completed NCT02591238 - Melatonin in Smoke-induced Vascular Injury Phase 4
Terminated NCT03598140 - Sildenafil Treatment for Mild TBI Phase 2
Recruiting NCT04937868 - Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
Recruiting NCT01668836 - Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years N/A
Available NCT03631056 - Individual Patient Expanded Access for Human Acellular Vessel (HAV)

External Links